Company remains on track to submit Investigational Device Exemption (“IDE”), and if approved, commence U.S. clinical trials in 2026 to support a De Novo FDA application THE WOODLANDS, TX, Sept. 29, ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

The "GLP Laboratory Compliance Documentation and Recordkeeping" training has been added to ResearchAndMarkets.com's offering.

CHALK RIVER, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization, is pleased to announce that the Chalk River ...

Telomir Pharmaceuticals (TELO) announced results from a comprehensive series of IND-enabling Good Laboratory Practice toxicology and safety ...

Visakhapatnam: Though 11 years have passed since the bifurcation of combined Andhra Pradesh, the residuary state still lacks a dedicated, state-level animal facility compliant with GLP (good ...